AzTrials
AzTrials

Gastric UltrasoundNCT04206111

Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

An observational study of Gastric Ultrasound, run by University of Liege at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Check in gastric ultrasound for lack of stomach insufflation during preoxygenation with high-flow nasal cannulas Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gastric Ultrasound
What is being tested?
Preoxygenation
Type of treatment
Surgery or procedure
How many people
50 participants
Where
1 siteBelgium
Study dates
1 Jun 2020to 1 Oct 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Adults

Who may be able to join

  • Adults Volunteers

Who cannot join

  • History of gastric surgery
  • Facial or oropharyngeal abnormality

Trial locations and contacts

1 site in 1 country.

Benjamin Javillier, MD contact

003243667180

benjamin.javillier@chuliege.be

Belgium1 site, 1 recruiting
  • Javillier

    Liège, 4000

    Benjamin Javillier, MD, 003243667180, benjamin.javillier@chuliege.be

    Recruiting

Other trials in Belgium

About this study

Check in gastric ultrasound for lack of stomach insufflation during preoxygenation with high-flow nasal cannulas

Being tested
Preoxygenation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PreoxygenationProcedure or surgery

    preoxygenation with high flow nasal cannula at 40l/min for 5min

Study groups in NCT04206111
Study groupRoleWhat they receive
PreoxygenationNot described
Receives: Procedure: Preoxygenation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. no gastric insufflation

    Number of Participants with no gastric insufflation

    Measured: From date of randomization until the date of first documented progression, whichever came first, assessed up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2019
  2. Study start1 Jun 2020
  3. Primary completion1 Sep 2020 (estimated)
  4. Study completion1 Oct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04206111
Sponsor's protocol ID
Optisafe
Status last verified
Jun 2020
First submitted
15 Dec 2019
Last updated
16 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gastric Ultrasound, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Benjamin Javillier, MD (003243667180, benjamin.javillier@chuliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

no gastric insufflation (time frame: From date of randomization until the date of first documented progression, whichever came first, assessed up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in